Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turkovac Booster Phase 3
NCT05077176Phase 3Completed
- Sponsor
- TÜSEB
- Start
- Oct 2021
- Primary completion
- May 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of turkovac in coronavirus disease 2019 (COVID-19), sponsored by TÜSEB. Started Oct 2021; status: completed.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05077176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05077176.